Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1990-06-27
1992-09-22
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Lymphokine
A61K 39149, A61K 3912
Patent
active
051495317
ABSTRACT:
A method of treating a patient for having influenza includes introducing intranasally into said patient a prophylactically or therapeutically effective dosage of an attenuated reassortant live influenza virus as an antiviral agent and effecting by said introduction immediate interference with the growth of said influenza virus.
REFERENCES:
patent: 4552758 (1985-11-01), Murphy et al.
Clements et al., The Lancet, (Mar. 31, 1984), pp. 705-708.
Monto et al., The J. of Infect. Dis., vol. 145, No. 1, Jan. 1982, pp. 57- 4.
Maassab, Adaptation and Growth Characteristics of Influenza Virus at 25.degree. C., Nature, Feb. 11, 1967, pp. 612-614.
Maassab, Biologic and Immunologic Characteristics of Cold-Adapted Influenza Virus, Jour. of Immunology, vol. 102, No. 3, pp. 728-732 (1969).
Murphy et al., Infec. Immun. 29, pp. 348-355 (1980).
Maassab et al., Evaluation of a Cold-Recombinant Influenza Virus Vaccine in Ferrets, Journal of Infectious Diseases, vol. 146, No. 6 (Dec. 1982).
Cox et al., Virology, 167, pp. 554-567 (1988).
Clements et al., Resistance of Adults to Challenge with Influenza a Wild-Type Virus After Receiving Live or Inactivated Virus Vaccine, Journal of Clinical Microbiology, vol. 23, No. 1, pp. 73-76 (1986).
Snyder et al., Journal of Virology, 62, pp. 488-495 (1988).
Whitaker Dowling et al., Dominance of Cold-Adapted Vaccine Strains of Influenza a Viruses etc., Genetics and Pathogenicity of Nagative Strand Viruses, Elsevier pp. 402-407 (1989).
Dowling Patricia W.
Youngner Julius S.
Cashion Jr. Merrell C.
Koh Choon
Silverman Arnold B.
University of Pittsburgh of the Commonwealth System of Higher Ed
LandOfFree
Method of using cold-adapted live influenza virus vaccine as an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of using cold-adapted live influenza virus vaccine as an , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using cold-adapted live influenza virus vaccine as an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1067043